Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Terumo (TRUMF)
OTHER OTC:TRUMF
Holding TRUMF?
Track your performance easily
TRUMF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$15.00 - $22.26
Previous Close$21.58
Volume1.01K
Average Volume (3M)6.09K
Market Cap
$30.15B
Enterprise Value$30.61B
Total Cash (Recent Filing)¥162.63B
Total Debt (Recent Filing)¥231.71B
Price to Earnings (P/E)40.4
Beta1.07
Next Earnings
Feb 06, 2025EPS Estimate
$0.17Next Dividend Ex-Date
Mar 28, 2025Dividend Yield0.75%
Share Statistics
EPS (TTM)0.53
Shares OutstandingN/A
10 Day Avg. Volume1,702
30 Day Avg. Volume6,092
Standard Deviation0.08
R-Squared0.22
Alpha-0.00254
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)3.80
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$22.34Price Target Upside3.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Terumo News
PremiumCompany Announcements
Terumo Corporation Reports Strong First Half 2024 Results
PremiumCompany Announcements
Terumo Corp Raises Financial Forecast Amid Strong Revenue
PremiumPre-Earnings
Is TRUMF a Buy, Before Earnings?PremiumCompany Announcements
Terumo Completes Share Buyback Program
PremiumCompany Announcements
Terumo Sets Dates for 30 Billion Yen Share Buyback
PremiumCompany Announcements
Terumo Sets Offer Price for International Share Sale
PremiumCompany Announcements
Terumo Announces Share Buyback and Cancellation PlanPremiumCompany Announcements
Terumo Announces Secondary Offering and Share Buyback PlanBulls Say, Bears Say
Bulls Say
Market ExpansionThe joint venture with Weigao Blood Purification allows Terumo to tap into China's large market, potentially increasing its market presence.
Material AdvancementsFollowing the market movement from predominantly glass-focused syringes to polymeric materials, Terumo offers benefits such as higher break resistance and less risk of reaction with drugs.
Product InnovationTerumo has been recognized for its innovative needle technology, making it a top choice for pharmaceutical packaging of popular GLP-1 weight loss drugs.
Bears Say
Growth PotentialThe delay in the IPO of Weigao Blood Purification on the HKEX could be detrimental to Terumo, as the listing could boost growth.
Market OpportunitiesThe delay in the IPO of Weigao Blood Purification could be detrimental to Terumo, as the listing could boost growth.
Pricing PressureThere is a risk of price cuts for hemodialysis systems in China due to the country's Volume Based Procurement scheme.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
8.51% Mutual Funds
<0.01% Other Institutional Investors
83.67% Public Companies and
Individual Investors
TRUMF FAQ
What was Terumo’s price range in the past 12 months?
Terumo lowest stock price was $15.00 and its highest was $22.26 in the past 12 months.
What is Terumo’s market cap?
Currently, no data Available
When is Terumo’s upcoming earnings report date?
Terumo’s upcoming earnings report date is Feb 06, 2025 which is in 45 days.
How were Terumo’s earnings last quarter?
Terumo released its earnings results on Nov 07, 2024. The company reported $0.129 earnings per share for the quarter, missing the consensus estimate of $0.145 by -$0.016.
Is Terumo overvalued?
According to Wall Street analysts Terumo’s price is currently Undervalued.
Does Terumo pay dividends?
Terumo pays a Annually dividend of $0.085 which represents an annual dividend yield of 0.75%. See more information on Terumo dividends here
What is Terumo’s EPS estimate?
Terumo’s EPS estimate is $0.17.
How many shares outstanding does Terumo have?
Terumo has 1,490,697,300 shares outstanding.
What happened to Terumo’s price movement after its last earnings report?
Terumo reported an EPS of $0.129 in its last earnings report, missing expectations of $0.145. Following the earnings report the stock price went up 10.022%.
Which hedge fund is a major shareholder of Terumo?
Currently, no hedge funds are holding shares in TRUMF
---
Terumo Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$22.34 (3.54% Upside)
$22.34 (3.54% Upside)
Blogger Sentiment
Bullish
TRUMF Sentiment 100%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.54%
12-Months-Change
Fundamentals
Return on Equity
9.00%
Trailing 12-Months
Asset Growth
4.55%
Trailing 12-Months
Company Description
Terumo
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan
---
TRUMF Company Deck
---
TRUMF Earnings Call
Q2 2024
0:00 / 0:00
---
TRUMF Stock 12 Month Forecast
Average Price Target
$22.34
▲(3.54% Upside)
Technical Analysis
Best Analysts Covering TRUMF
1 Year
1 Year Success Rate
3/3 ratings generated profit
1 Year Average Return
+12.90%
reiterated a buy rating 4 months ago
Copying Stephen Barker's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +12.90% per trade.
---